Annual report [Section 13 and 15(d), not S-K Item 405]

Income Taxes - Additional Information (Details)

v3.25.1
Income Taxes - Additional Information (Details) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Valuation allowance $ 89,403 $ 87,257
Unrecognized tax benefits interest and penalties accrued 0 $ 0
Research and development credit carryforwards    
Tax credit Carryforward, Amount $ 5,300  
Tax credit carryforward, expiration date Dec. 31, 2034  
Orphan drug credit carryforwards    
Tax credit Carryforward, Amount $ 1,500  
Tax credit carryforward, expiration date Dec. 31, 2034  
Federal    
Operating Loss Carryforwards $ 196,600  
Operating loss carryforwards indefinitely amount 165,500  
Operating loss carryforwards remaining amount $ 31,200  
Operating loss carry forwards expiration period 2034  
State and Local    
Operating Loss Carryforwards $ 152,400  
Operating loss carryforwards indefinitely amount 1,500  
Operating loss carryforwards remaining amount $ 150,900  
Operating loss carry forwards expiration period 2034